Partners
The NutriEV project integrates a diverse range of disciplines, including nutrition, microbiome research, glycan analysis, molecular biology, nanoreagent assembly, biosensors, organoid technologies, in vivo models, and clinical research. By synergizing these fields, the initiative aims to advance in the study of nutritional extracellular vesicles and explore their potential as superfoods and nutritional biosensors.
University of Oulu
The University of Oulu is a multidisciplinary institution located in Northern Finland, with approximately 14,000 students spread across eight faculties, including 26 international master’s programs. The University also hosts several interdisciplinary institutes, such as the Kvantum Institute and Infotech Oulu.
The Faculty of Biochemistry and Molecular Medicine (FBMM), situated at the University Medical Campus adjacent to Oulu University Hospital, is internationally recognized for its expertise in collagen research, integrative structural biology, hypoxia research, cancer biology, biotechnology, and preclinical disease models.
Principal Investigator: Seppo Vainio
Seppo is a professor and Research Director for University of Oulu’s Kvantum Institute. He is a codirector of the GeneCellNano Flagship Consortium that targets the fundamentals of ATMP development using gene, cell and nano technologies, including EVs.
With the support of:
Zhi Chen: Immunologist specializing in T helper cells and their role in inflammation, using systems biology and murine models to study Th subsets in inflammation and autoimmunity, with numerous highly cited publications.
Terhi Tapiainen: Paediatrics professor at Oulu University Hospital, focusing on the gut’s role in diseases, with research on cohorts of obese and non-obese mothers and their offspring.
Olli Loukola: Expert in animal cognition and behaviour, recognized for groundbreaking work on training bumblebees to solve complex tasks and detect reward-related odors.
Consiglio Nazionale delle Ricerche
The Consiglio Nazionale delle Ricerche (CNR) is Italy’s largest public research institution, founded in 1923. Its mission includes conducting research, promoting innovation, and supporting national competitiveness. CNR also aids government bodies, fosters internationalization, and contributes to human resource development. With over 8,000 employees, more than half are researchers and technologists. Additionally, 4,000 young researchers and research associates from universities or
private firms contribute to CNR’s priority research areas.
Principal Investigator: Gabriella Pocsfalvi
Gabriella, Research Director at CNR’s Institute of Biosciences and BioResources, specializes in plant EVs, focusing on their isolation, characterization, loading and labelling and biotech exploitation.
Technical University of Braunschweig
The Technische Universität Braunschweig, founded in 1745 as Collegium Carolinum, is the oldest university of technology in Germany. It is a member of TU9, an alliance of nine leading technical universities in the country. The university has over 16,000 students and more than 240 professors.
The departments of Biotechnology and Medical Biotechnology focus on antibody engineering for diagnostics and therapy, as well as research on biomarkers. Antibodies developed by these departments have been tested in clinical trials.
Principal Investigator: Michael Hust
Michael is an expert in antibody engineering and phage display. He has published over 190 articles and filed several patents in the fields of antibody engineering and phage display.
University of Copenhagen
Since 1479, the University of Copenhagen has advanced global knowledge. With 5,000 researchers and 36,500 students, it ranks among the world’s top universities, offering an international research and study environment. The University supports talent development through research-based teaching, involving students in real-world research to equip them for addressing societal challenges. Ambitious interdisciplinary initiatives strengthen its academic communities, fostering innovation and collaboration across diverse fields of study.
Principal Investigator: Hans H. Wandall
Hans, a professor at the Copenhagen Center for Glycomics, specializes in glycan biology and functional analysis, mapping glycan structures and their impact on cellular differentiation using genetic engineering technologies.
Zabala Innovation
Established in 1986, Zabala Innovation is a consultancy specializing in facilitating access to grant funding worldwide. With a team of over 500 employees and offices in Spain, Belgium, France, and Portugal, the company offers extensive expertise in Social Innovation, Stakeholder Engagement, and Research and Technological Development (RTD) Management. Zabala Innovation is committed to advancing social development, promoting human rights globally, and fostering international cooperation. Supporting over 600 European organizations, the firm consistently delivers impactful solutions through collaboration and exemplary performance.
